Home Tags CheckMate 012

Tag: CheckMate 012

CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in...

By Neal Ready, MD, PhD Posted: February 12, 2020 Programmed death receptor (PD-1) checkpoint monoclonal antibody therapy has proven a major advancement in the management of...

Meeting News